Total Payments
$509.22
2024 Payments
$166.06
Companies
11
Transactions
17
Medicare Patients
1,727
Medicare Billing
$236,164
Payment Breakdown by Category
Food & Beverage$309.26 (60.7%)
Education$174.96 (34.4%)
Gifts$25.00 (4.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $309.26 | 10 | 60.7% |
| Education | $174.96 | 6 | 34.4% |
| Gift | $25.00 | 1 | 4.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| BeiGene USA, Inc. | $137.15 | 1 | $0 (2024) |
| Amgen Inc. | $99.99 | 1 | $0 (2019) |
| Genentech USA, Inc. | $93.16 | 5 | $0 (2023) |
| Eisai Inc. | $36.40 | 2 | $0 (2021) |
| ABBVIE INC. | $28.91 | 1 | $0 (2024) |
| Tosoh Bioscience, Inc. | $25.00 | 1 | $0 (2019) |
| Kyowa Kirin, Inc. | $23.50 | 1 | $0 (2023) |
| PFIZER INC. | $22.80 | 2 | $0 (2018) |
| Stemline Therapeutics Inc. | $16.75 | 1 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $13.64 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $166.06 | 2 | BeiGene USA, Inc. ($137.15) |
| 2023 | $61.70 | 3 | Genentech USA, Inc. ($38.20) |
| 2022 | $36.06 | 2 | Genentech USA, Inc. ($36.06) |
| 2021 | $53.48 | 3 | Eisai Inc. ($22.66) |
| 2020 | $30.49 | 2 | Stemline Therapeutics Inc. ($16.75) |
| 2019 | $124.99 | 2 | Amgen Inc. ($99.99) |
| 2018 | $25.04 | 2 | Janssen Pharmaceuticals, Inc ($13.64) |
| 2017 | $11.40 | 1 | PFIZER INC. ($11.40) |
All Payment Transactions
17 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/08/2024 | ABBVIE INC. | ELAHERE (Drug) | Food and Beverage | In-kind items and services | $28.91 | General |
| Category: ONCOLOGY | ||||||
| 02/22/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $137.15 | General |
| Category: Oncology | ||||||
| 07/19/2023 | Kyowa Kirin, Inc. | Poteligeo (Drug) | Education | In-kind items and services | $23.50 | General |
| Category: Monoclonal Antibody | ||||||
| 03/30/2023 | Genentech USA, Inc. | Venclexta (Biological) | Food and Beverage | In-kind items and services | $19.10 | General |
| Category: BioOncology | ||||||
| 02/28/2023 | Genentech USA, Inc. | Venclexta (Biological) | Food and Beverage | In-kind items and services | $19.10 | General |
| Category: BioOncology | ||||||
| 12/08/2022 | Genentech USA, Inc. | VENCLEXTA (Biological) | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: BioOncology | ||||||
| 06/02/2022 | Genentech USA, Inc. | VENCLEXTA (Biological) | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: BioOncology | ||||||
| 12/13/2021 | Genentech USA, Inc. | VENCLEXTA (Biological) | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: BioOncology | ||||||
| 08/16/2021 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $22.66 | General |
| Category: Oncology | ||||||
| 06/01/2021 | Gilead Sciences, Inc. | — | Education | In-kind items and services | $11.92 | General |
| 04/12/2020 | Stemline Therapeutics Inc. | ELZONRIS (Drug) | Education | In-kind items and services | $16.75 | General |
| Category: ONCOLOGY | ||||||
| 03/10/2020 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $13.74 | General |
| Category: Oncology | ||||||
| 05/09/2019 | Tosoh Bioscience, Inc. | G8 Elution Buffer No. 1, 800mL (Medical Supply), G8 elution Buffer No. 2, 800mL, G8 Elution Buffer No. 3, 800mL | Gift | In-kind items and services | $25.00 | General |
| Category: Hematology | ||||||
| 03/13/2019 | Amgen Inc. | — | Education | In-kind items and services | $99.99 | General |
| 03/26/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/23/2018 | PFIZER INC. | SUTENT (Drug) | Education | In-kind items and services | $11.40 | General |
| Category: ONCOLOGY;RESPIRATORY | ||||||
| 12/08/2017 | PFIZER INC. | SUTENT (Drug) | Education | In-kind items and services | $11.40 | General |
| Category: ONCOLOGY;RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 351 | 793 | $184,206 | $56,795 |
| 2022 | 4 | 411 | 839 | $205,631 | $60,358 |
| 2021 | 5 | 456 | 836 | $191,152 | $66,315 |
| 2020 | 6 | 509 | 890 | $194,420 | $52,696 |
Total Patients
1,727
Total Services
3,358
Medicare Billing
$236,164
Procedure Codes
19
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 254 | 596 | $133,051 | $39,912 | 30.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 23 | 113 | $34,374 | $11,922 | 34.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 57 | 67 | $10,218 | $3,284 | 32.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 17 | 17 | $6,563 | $1,677 | 25.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 269 | 586 | $136,726 | $39,862 | 29.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 25 | 120 | $37,840 | $12,563 | 33.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 88 | 104 | $16,452 | $5,023 | 30.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 29 | 29 | $14,613 | $2,911 | 19.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 272 | 570 | $128,250 | $45,055 | 35.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 27 | 88 | $26,840 | $10,250 | 38.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 113 | 134 | $20,574 | $6,665 | 32.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 30 | 30 | $12,230 | $3,354 | 27.4% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 14 | 14 | $3,258 | $990.28 | 30.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 240 | 509 | $114,525 | $30,033 | 26.2% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 36 | 121 | $36,905 | $10,871 | 29.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 154 | 175 | $26,775 | $6,283 | 23.5% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 21 | 21 | $7,287 | $2,159 | 29.6% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 32 | 38 | $2,934 | $1,884 | 64.2% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 26 | 26 | $5,994 | $1,466 | 24.5% |
About Dr. Rachel Harper, M.D
Dr. Rachel Harper, M.D is a Hematology & Oncology healthcare provider based in Lexington, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1831124379.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rachel Harper, M.D has received a total of $509.22 in payments from pharmaceutical and medical device companies, with $166.06 received in 2024. These payments were reported across 17 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($309.26).
As a Medicare-enrolled provider, Harper has provided services to 1,727 Medicare beneficiaries, totaling 3,358 services with total Medicare billing of $236,164. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Other Specialties Medical Oncology, Hematology
- Location Lexington, KY
- Active Since 07/12/2006
- Last Updated 06/05/2019
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1831124379
Products in Payments
- BRUKINSA (Drug) $137.15
- VENCLEXTA (Biological) $54.96
- Venclexta (Biological) $38.20
- Lenvima (Drug) $36.40
- ELAHERE (Drug) $28.91
- G8 Elution Buffer No. 1, 800mL (Medical Supply) $25.00
- Poteligeo (Drug) $23.50
- SUTENT (Drug) $22.80
- ELZONRIS (Drug) $16.75
- XARELTO (Drug) $13.64
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Lexington
Dr. Nicola Jabbour, M.d, M.D
Hematology & Oncology — Payments: $611,455
Hematology & Oncology $611,455
Dr. Lowell Anthony, M.d, M.D
Hematology & Oncology — Payments: $64,060
Hematology & Oncology $64,060
Dr. Zhonglin Hao, Md, Phd, MD, PHD
Hematology & Oncology — Payments: $22,675
Hematology & Oncology $22,675
John Villano
Hematology & Oncology — Payments: $17,051
Hematology & Oncology $17,051
Dr. Jessica Croley, Md, MD
Hematology & Oncology — Payments: $13,189
Hematology & Oncology $13,189
Mr. Russell Eldridge, Md, MD
Hematology & Oncology — Payments: $10,781
Hematology & Oncology $10,781